Drug Repurposing to Treat Glucocorticoid Resistance in Asthma

Drug Repurposing to Treat Glucocorticoid Resistance in Asthma

Corticosteroid resistance causes significant morbidity in asthma, and drug repurposing may identify timely and cost-effective adjunctive treatments for corticosteroid resistance. In 95 subjects from the Childhood Asthma Management Program (CAMP) and 19 subjects from the Severe Asthma Research Progra...

Full description

Bibliographic Details
Main Authors: Alberta L. Wang, Ronald Panganiban, Weiliang Qiu, Alvin T. Kho, Geoffrey Chupp, Deborah A. Meyers, Eugene R. Bleecker, Scott T. Weiss, Quan Lu, Kelan G. Tantisira
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Personalized Medicine
Subjects:
asthma
anti-asthmatic agents
drug repositioning
glucocorticoid effect
Online Access:https://www.mdpi.com/2075-4426/11/3/175

Internet

https://www.mdpi.com/2075-4426/11/3/175

Similar Items